Tanya Bubner
Overview
Explore the profile of Tanya Bubner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
234
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Middleton P, Bubner T, Glover K, Rumbold A, Weetra D, Scheil W, et al.
Aust N Z J Public Health
. 2016 Nov;
41(1):21-26.
PMID: 27868308
Objectives: To evaluate implementation and outcomes of the Aboriginal Family Birthing Program (AFBP), which provides culturally competent antenatal, intrapartum and early postnatal care for Aboriginal families across South Australia (SA)....
2.
Spencer L, Bubner T, Bain E, Middleton P
Cochrane Database Syst Rev
. 2015 Sep;
(9):CD011263.
PMID: 26387772
Background: Thyroid dysfunction pre-pregnancy and during pregnancy (both hyper- and hypothyroidism) is associated with increased risk of adverse outcomes for mothers and infants in the short- and long-term. Managing the...
3.
Bain E, Bubner T, Ashwood P, Van Ryswyk E, Simmonds L, Reid S, et al.
BMC Pregnancy Childbirth
. 2015 Aug;
15:176.
PMID: 26283623
Background: Strong evidence supports administration of magnesium sulphate prior to birth at less than 30 weeks' gestation to prevent very preterm babies dying or developing cerebral palsy. This study was...
4.
Siwicki K, Bain E, Bubner T, Ashwood P, Middleton P, Crowther C
Aust N Z J Obstet Gynaecol
. 2015 Jun;
55(3):233-8.
PMID: 26084194
Background: Australian and New Zealand clinical practice guidelines, endorsed by the NHMRC in 2010, recommend administration of antenatal magnesium sulphate to women at risk of imminent preterm birth at less...
5.
Crowther C, Middleton P, Bain E, Ashwood P, Bubner T, Flenady V, et al.
BMC Pregnancy Childbirth
. 2013 Dec;
13:239.
PMID: 24354790
Background: Babies born very preterm (before 30 weeks gestation) are at high risk of dying in their first weeks of life, and those who survive are at risk of developing...
6.
Bain E, Goodchild L, Lontis R, McIntyre S, Ashwood P, Bubner T, et al.
Aust Nurs J
. 2013 Aug;
21(1):34-7.
PMID: 23930314
No abstract available.
7.
Bain E, Bubner T, Ashwood P, Crowther C, Middleton P
Aust N Z J Obstet Gynaecol
. 2012 Oct;
53(1):86-9.
PMID: 23106226
Health professionals at 25 Australian and New Zealand tertiary maternity hospitals were surveyed about local implementation of a clinical practice guideline for antenatal magnesium sulphate for fetal neuroprotection. Seventy-six percent...
8.
Bubner T, Laurence C, Tirimacco R
Aust Fam Physician
. 2012 Sep;
41(9):721-4.
PMID: 22962652
Background: The number of pathology tests ordered by general practitioners is rising. Some of this increase may reflect overtesting, overutilisation or training deficiency. The aim of this study was to...
9.
Laurence C, Gialamas A, Bubner T, Yelland L, Willson K, Ryan P, et al.
Br J Gen Pract
. 2010 Mar;
60(572):e98-104.
PMID: 20202351
Background: Point-of-care testing is increasingly being used in general practice to assist GPs in their management of patients with chronic disease. However, patient satisfaction and acceptability of point-of-care testing in...
10.
Shephard M, Mazzachi B, Watkinson L, Shephard A, Laurence C, Gialamas A, et al.
Rural Remote Health
. 2009 Aug;
9(3):1189.
PMID: 19689171
Introduction: From September 2005 to February 2007 the Australian Government funded the Point of Care Testing (PoCT) in General Practice Trial, a multi-centre, cluster randomised controlled trial to determine the...